The clinical relevance and prognostic significance of adenosine triphosphate ATP-binding cassette (ABCB5) and multidrug resistance (MDR1) genes expression in acute leukemia: an Egyptian study
- 8 May 2014
- journal article
- Published by Springer Science and Business Media LLC in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 140 (8), 1323-1330
- https://doi.org/10.1007/s00432-014-1694-3
Abstract
Multidrug resistance (MDR1) represents a major obstacle in the chemotherapeutic treatment of acute leukemia (AL). Adenosine triphosphate ATP-binding cassette (ABCB5) and MDR1 genes are integral membrane proteins belonging to ATP-binding cassette transporters superfamily. The present work aimed to investigate the impact of ABCB5 and MDR1 genes expression on the response to chemotherapy in a cohort of Egyptian AL patients. The study included 90 patients: 53 AML cases and 37 ALL cases in addition to 20 healthy volunteers as controls. Quantitative assessment of MDR1 and ABCB5 genes expression was performed by quantitative real-time polymerase chain reaction. Additional prognostic molecular markers were determined as internal tandem duplications of the FLT3 gene (FLT3-ITD) and nucleophosmin gene mutation (NPM1) for AML cases, and mbcr-abl fusion transcript for B-ALL cases. In AML patients, ABCB5 and MDR1 expression levels did not differ significantly between de novo and relapsed cases and did not correlate with the overall survival or disease-free survival. AML patients were stratified according to the studied genetic markers, and complete remission rate was found to be more prominent in patients having low expression of MDR1 and ABCB5 genes together with mutated NPM1 gene. In ALL patients, ABCB5 gene expression level was significantly higher in relapsed cases and MDR1 gene expression was significantly higher in patients with resistant disease. In conclusion, the results obtained by the current study provide additional evidence of the role played by these genes as predictive factors for resistance of leukemic cells to chemotherapy and hence treatment outcome.This publication has 44 references indexed in Scilit:
- Therapeutic Efficacy and Safety of Paclitaxel/Lonidamine Loaded EGFR-Targeted Nanoparticles for the Treatment of Multi-Drug Resistant CancerPLOS ONE, 2011
- Identification of cells initiating human melanomasNature, 2008
- Evaluation of complete disease remission in acute myeloid leukemiaCancer, 2006
- INCREASED EXPRESSION OF MULTIDRUG RESISTANCE GENE (MDR1) AT RELAPSE IN A CHILD WITH ACUTE LYMPHOBLASTIC LEUKEMIAPediatric Hematology and Oncology, 2006
- Mechanisms of Drug Resistance in Cancer ChemotherapyMedical Principles and Practice, 2005
- ABCB5-Mediated Doxorubicin Transport and Chemoresistance in Human Malignant MelanomaCancer Research, 2005
- Principal expression of two mRNA isoforms (ABCB 5α and ABCB 5β ) of the ATP‐binding cassette transporter gene ABCB 5 in melanoma cells and melanocytesPigment Cell Research, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- MDR1 mRNA Expression In Young Patients With Acute Lymphoblastic LeukaemiaBritish Journal of Haematology, 2000
- MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemiaBritish Journal of Haematology, 1990